Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 6Phase 1 3Phase 2/3 2Phase 1/2 2

Status

Active not recruiting 2

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 15Neoplasm Metastasis 13Squamous Cell Carcinoma of Head and Neck 11Neoplasms 11Prostatic Neoplasms 10Breast Neoplasms 9Recurrence 7Ovarian Neoplasms 7Myasthenia Gravis 7Lung Neoplasms 7Leukemia, Myeloid, Acute 7Stomach Neoplasms 6Head and Neck Neoplasms 6Colorectal Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Fatigue 5Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Melanoma 4Fallopian Tube Neoplasms 4Colonic Neoplasms 4Urinary Bladder Neoplasms 3Rectal Neoplasms 3Peritoneal Neoplasms 3Mouth Neoplasms 3Glioblastoma 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Anorexia 3Adenocarcinoma Of Esophagus 3

Interventions

Platinum 1Paclitaxel 1Lymph Node Excision 1Gemcitabine 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Gallbladder Neoplasms × 90 days × Clear all
NCT05506943 2026-05-07

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Compass Therapeutics

Phase 2/3 Active not recruiting
168 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT04559139 2026-05-01

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

Eastern Cooperative Oncology Group

Phase 2/3 Active not recruiting
186 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡